Tag: iPSC derived cardiomyocytes
-
iPSC Derived Cardiomyocytes and 3D Tissue Contractility Analysis | NEXEL
NEXEL Co., Ltd. is committed to becoming a world-class biotech company. Its aim is to develop innovative new therapies to help patients and provide tools for researchers to boost their projects. Thus, they will create value for the investors, fellow researchers, and the world to make a better place. NEXEL is a world leader in iPSC…